BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25430462)

  • 1. Engineering skeletal muscle tissue in bioreactor systems.
    An Y; Li D
    Chin Med J (Engl); 2014; 127(23):4130-9. PubMed ID: 25430462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current opportunities and challenges in skeletal muscle tissue engineering.
    Koning M; Harmsen MC; van Luyn MJ; Werker PM
    J Tissue Eng Regen Med; 2009 Aug; 3(6):407-15. PubMed ID: 19575392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic mechanical preconditioning improves engineered muscle contraction.
    Moon du G; Christ G; Stitzel JD; Atala A; Yoo JJ
    Tissue Eng Part A; 2008 Apr; 14(4):473-82. PubMed ID: 18399787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue engineering of osteochondral constructs in vitro using bioreactors.
    Haasper C; Zeichen J; Meister R; Krettek C; Jagodzinski M
    Injury; 2008 Apr; 39 Suppl 1():S66-76. PubMed ID: 18313474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic mechanical stimulation favors myosin heavy chain accumulation in engineered skeletal muscle constructs.
    Candiani G; Riboldi SA; Sadr N; Lorenzoni S; Neuenschwander P; Montevecchi FM; Mantero S
    J Appl Biomater Biomech; 2010; 8(2):68-75. PubMed ID: 20740468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Bioreactor to Culture Tissue Engineered Ureters Based on the Application of Tubular OPTIMAIX 3D Scaffolds.
    Seifarth V; Gossmann M; Janke HP; Grosse JO; Becker C; Heschel I; Artmann GM; Temiz Artmann A
    Urol Int; 2015; 95(1):106-13. PubMed ID: 25633970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three dimensional multi-cellular muscle-like tissue engineering in perfusion-based bioreactors.
    Cerino G; Gaudiello E; Grussenmeyer T; Melly L; Massai D; Banfi A; Martin I; Eckstein F; Grapow M; Marsano A
    Biotechnol Bioeng; 2016 Jan; 113(1):226-36. PubMed ID: 26126766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and progress of engineering of skeletal muscle tissue.
    Liao H; Zhou GQ
    Tissue Eng Part B Rev; 2009 Sep; 15(3):319-31. PubMed ID: 19591626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioreactor systems for bone tissue engineering.
    Rauh J; Milan F; Günther KP; Stiehler M
    Tissue Eng Part B Rev; 2011 Aug; 17(4):263-80. PubMed ID: 21495897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered skeletal muscle tissue for soft robotics: fabrication strategies, current applications, and future challenges.
    Duffy RM; Feinberg AW
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2014; 6(2):178-95. PubMed ID: 24319010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pulsatile bioreactor culture on vascular smooth muscle cells seeded on electrospun poly (lactide-co-ε-caprolactone) scaffold.
    Mun CH; Jung Y; Kim SH; Kim HC; Kim SH
    Artif Organs; 2013 Dec; 37(12):E168-78. PubMed ID: 23834728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioreactors in tissue engineering - principles, applications and commercial constraints.
    Hansmann J; Groeber F; Kahlig A; Kleinhans C; Walles H
    Biotechnol J; 2013 Mar; 8(3):298-307. PubMed ID: 23161827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A versatile modular bioreactor platform for Tissue Engineering.
    Schuerlein S; Schwarz T; Krziminski S; Gätzner S; Hoppensack A; Schwedhelm I; Schweinlin M; Walles H; Hansmann J
    Biotechnol J; 2017 Feb; 12(2):. PubMed ID: 27492568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioreactors as engineering support to treat cardiac muscle and vascular disease.
    Massai D; Cerino G; Gallo D; Pennella F; Deriu MA; Rodriguez A; Montevecchi FM; Bignardi C; Audenino A; Morbiducci U
    J Healthc Eng; 2013; 4(3):329-70. PubMed ID: 23965594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascularisation in regenerative therapeutics and surgery.
    Jeyaraj R; G N; Kirby G; Rajadas J; Mosahebi A; Seifalian AM; Tan A
    Mater Sci Eng C Mater Biol Appl; 2015 Sep; 54():225-38. PubMed ID: 26046286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular tissue engineering I. Perfusion bioreactors: a review.
    Mironov V; Kasyanov VA; Yost MJ; Visconti R; Twal W; Trusk T; Wen X; Ozolanta I; Kadishs A; Prestwich GD; Terracio L; Markwald RR
    J Long Term Eff Med Implants; 2006; 16(2):111-30. PubMed ID: 16700652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in skeletal muscle tissue engineering.
    Stern-Straeter J; Riedel F; Bran G; Hörmann K; Goessler UR
    In Vivo; 2007; 21(3):435-44. PubMed ID: 17591352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational fluid dynamics modeling of steady-state momentum and mass transport in a bioreactor for cartilage tissue engineering.
    Williams KA; Saini S; Wick TM
    Biotechnol Prog; 2002; 18(5):951-63. PubMed ID: 12363345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of perfusion bioreactors and large animal models for long bone tissue engineering.
    Gardel LS; Serra LA; Reis RL; Gomes ME
    Tissue Eng Part B Rev; 2014 Apr; 20(2):126-46. PubMed ID: 23924374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New pulsatile hydrostatic pressure bioreactor for vascular tissue-engineered constructs.
    Shaikh FM; O'Brien TP; Callanan A; Kavanagh EG; Burke PE; Grace PA; McGloughlin TM
    Artif Organs; 2010 Feb; 34(2):153-8. PubMed ID: 19995361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.